Re: Thoughts on ZCC
in response to
by
posted on
Sep 15, 2021 02:31PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
I agree that he needs to say less of promises that he might not keep but that doesn't interfere with reporting what has happened. If it is causes out of his control, he can tell us what happened. Right now, it mostly keeps pointing at their abyssmal financial situation and the markets aren't liking that. His exuberance of last spring and none of it coming to fruitition or even starting has just made it look like he has no clue how this industry operates even though he is paid as if he is a knowledgeable CEO. A CEO that appears to not know what he is doing doesn't sell well to the market. If he does know what he is doing, he needs to step up and show us either by getting it done or explaining what went wrong. Hiding does not sell!